Insider · CIK 0001737428
Chintu Patel
ceoofficerdirector
Files at AMRX (Amneal Pharmaceuticals, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +579,710 | - | - | 1,092,276 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | FTax withholding Class A Common Stock | -274,307 | $8.76 | $2.4M | 817,969 | Mar 5, 2025 |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +92,592 | - | - | 910,561 | Mar 5, 2025 |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | FTax withholding Class A Common Stock | -46,528 | $8.84 | $411k | 864,033 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Performance-Based Restricted Stock Unitsderivative | -579,710 | $0.00 | $0 | 0 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | AGrant or award Performance-Based Restricted Stock Unitsderivative | +890,410 | $0.00 | $0 | 890,410 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +239,726 | $0.00 | $0 | 239,726 | Mar 5, 2025 |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -92,592 | $0.00 | $0 | 277,778 | Mar 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.